DENDREON SAN DIEGO LLC has a total of 14 patent applications. Its first patent ever was published in 2000. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and machines are SILENCE THERAPEUTICS AG, VET STEM INC and NEURONYX INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | Canada | 4 | |
#3 | Australia | 3 | |
#4 | New Zealand | 1 | |
#5 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Machines | |
#4 | Agriculture | |
#5 | Measurement |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Unspecified technologies | |
#5 | Animal care | |
#6 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Madison Edwin L | 14 |
#2 | Ong Edgar O | 9 |
#3 | Yeh Jiunn-Chern | 4 |
#4 | Semple Joseph Edward | 3 |
#5 | Komandla Mallareddy | 2 |
#6 | Vlasuk George P | 2 |
#7 | Siev Daniel Vanna | 2 |
#8 | Kemp Scott Jeffrey | 2 |
#9 | Araldi Gian Luca | 1 |
#10 | Coombs Gary Samuel | 1 |
Publication | Filing date | Title |
---|---|---|
AU2003247776A1 | Serine protease 16 | |
AU2003269880A1 | Nucleic acid molecules encoding a transmembrane serine protease 12, the encoded polypeptides and methods based thereon | |
AU2002315525A1 | Nucleic acid molecules encoding a transmembrane serine protease 20, the encoded polypeptides and methods based thereon | |
WO02095007A2 | Conjugates activated by cell surface proteases and therapeutic uses thereof | |
WO02092841A2 | Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon | |
US6797504B1 | Inhibitors of serine protease activity of matriptase or MTSP1 |